Latest News
Valeant Pharma acquires Dow Pharma Sciences
Pharmabiz.com (India) | 29 minutes ago
Valeant Pharmaceuticals International announced that effective December 31, 2008, the company completed its acquisition of Dow Pharmaceutical Sciences, Inc, a privately held dermatology company that specializes in the development of topical products on a proprietary basis, as well as for pharmaceutical and biotechnology companies.... (more)
Acura submits NDA for Acurox tabs
Pharmabiz.com (India) | 3 hours 7 minutes ago
Acura Pharmaceuticals, Inc and King Pharmaceuticals, Inc announced that Acura has submitted a New Drug Application (NDA) for Acurox (oxycodone HCl/niacin) tablets to the US Food and Drug Administration (FDA) including a request for priority review. The FDA is expected to determine whether to accept the NDA for filing and consider the priority review request within 60 days. If approved, Acura and King believe Acurox will be the first FDA approved immediate release opioid analgesic designed to ...... (more)
Daiichi to write-down loss of $3.98 bn in Q3 for Ranbaxy acquisition
Pharmabiz.com (India) | 3 hours 7 minutes ago
Daiichi Sankyo Company, Japan has announced that it has decided to write-down a valuation loss on its investments in Ranbaxy Laboratories for Q3 to the tune of US$3.98 billion (359.5 billion Yen). This worked out to a more than 50 per cent decline in the market value of these securities versus the purchase price. Currently, Ranbaxy scrip is moving around Rs 250 on Bombay Stock Exchange as against Daiichi's purchased price of Rs 737.... (more)
Food Markets - Forbes.com
Forbes | 5 hours ago
The coming year holds particular promise for the food market industry, as hard-pressed consumers are limiting restaurant dining in favor of preparing more meals at home. That means more shoppers are hitting grocery store aisles in search of the lowest prices and easy meal options. According to San Francisco research outfit StarMine, Argus Research's Erin Ashley Smith is one of the most bullish analysts tracking the industry, while Morgan Stanley's Mark Wiltamuth is in the bearish category.... (more)
Endo buy widens its drug offerings | delawareonline | The News Journal
News Journal (Del.), The | 5 hours 4 minutes ago
Endo Pharmaceuticals said Monday it has reached an agreement to buy a smaller pharmaceutical company in a deal that would bolster Endo's pipeline of treatment candidates and expand its business beyond pain medications.... (more)
After years of research, tons of money, Memphis firm seeks FDA approval to sell Acapodene : Business News : Memphis Commercial Appeal
Commercial Appeal (Memphis, Tenn.), The | 5 hours 7 minutes ago
Last week, two electronic discs packed with data arrived at a Food and Drug Administration office in Beltsville, Md.... (more)
Tekmira Partner Alnylam Files First IND For An RNAi Therapeutic Utilizing SNALP
Bioresearch Online | 5 hours 13 minutes ago
Tekmira Pharmaceuticals Corporation announced recently that one of the company's collaborators, Alnylam Pharmaceuticals Inc., has filed an Investigational New Drug (IND) application with the United States Food and Drug Administration (FDA) seeking approval to begin a human clinical trial for a product candidate utilizing Tekmira's SNALP delivery technology.... (more)
Sangamo Biosciences Announces License Agreement With Pfizer For Zinc Finger Nucleases For Protein Production
Bioresearch Online | 5 hours 13 minutes ago
Sangamo BioSciences, Inc. , the leading developer of zinc finger DNA-binding proteins (ZFPs), recently announced an agreement to provide Pfizer Inc with a worldwide, non-exclusive license for the use of certain ZFP Nuclease (ZFNs) reagents to permanently eliminate the Glutamine Synthetase (GS) gene in Chinese Hamster Ovary (CHO) cell lines and for the use of these ZFN-modified cells for clinical and commercial production of therapeutic proteins. Under the terms of the agreement Sangamo will r...... (more)
Cell Biologists Identify New Tumor Suppressor For Lung Cancer
Bioresearch Online | 5 hours 13 minutes ago
Cancer and cell biology experts at the University of Cincinnati (UC) have identified a new tumor suppressor that may help scientists develop more targeted drug therapies to combat lung cancer.... (more)
Books and Media
Sacramento Bee (Calif.), The | 5 hours 36 minutes ago
"I write about the issues I care about, and I know it's a luxury to have an audience for that," said author Richard North Patterson.... (more)
Living Here
Sacramento Bee (Calif.), The | 5 hours 36 minutes ago
"I write about the issues I care about, and I know it's a luxury to have an audience for that," said author Richard North Patterson.... (more)
Semiconductor association calls for anti-counterfeiting plan - 11/1/2007 9:58:00 AM - Purchasing
Purchasing.com | 5 hours 38 minutes ago
The Semiconductor Industry Association (SIA) says it supports a plan to develop a semiconductor anti-counterfeiting trade agreement.... (more)
Cloud Computing Looms Larger on Corporate Horizon
NewsFactor Network | 5 hours 42 minutes ago
For all the potential and hype surrounding cloud computing, breaking old habits won't be easy -- particularly with business-software powerhouses Microsoft, IBM Corp., Oracle Corp. and SAP AG all maneuvering to protect their existing, lucrative software franchises while also setting up their own online services to compete with the industry upstarts. ... (more)
128 Stories | 
RSS Feed
Sign up for AANP SmartBrief
Latest Blog Postsview more
How To: Break Bad Habits and Build Good Habits
Diet-Blog
The 5 Worst Fast Food Value Meals
Diet-Blog
Let's Reboot America's Health IT Conversation Part 2: Beyond EHRs
Health Care Blog, The
Companies in the news
- Amgen Inc.
- Biovail Corp
- Caraco Pharmaceutical
- CareFirst
- Fresenius Medical Care
- Genentech Inc
- Health Care
- Labopharm Inc
- Logistics
- Mosaic
- Patterson
- Ranbaxy Laboratories Ltd.
- Sankyo Co LTD
- Shelby County
- St. Jude Children Research Hospital